In addition to the Omega-3 Whole Blood Test, Nutrasource offers additional tests that can be used either together or individually to assess the risk of cardiovascular disease. These tests are:
- PLAC® Test
- CardioMPO™ Test
- ASA Effect™ Test
Each of the above tests is intimately linked with levels of inflammation, which has been accepted by health care practitioners as a silent killer.
The famous Framingham Study has demonstrated that 50% of cardiovascular events occur in patients with unremarkable lipid levels. This means that traditionally measured biomarkers are simply not enough to accurately determine individual risk.
In partnership with key diagnostic companies, these cardiovascular tests are designed to provide Canadians with an integrative and complementary approach to routine cardiovascular risk assessment.
The figure below demonstrates how these four tests may be used to complement each other and can help determine which test or combination of tests may be right for you. This representation of an artery shows a progressive thickening with atherosclerotic plaque, and where along this progression from low to high risk each cardiac test can be used effectively.
ASA Effect™ Test
IS YOUR ASA WORKING FOR YOU?
Assess the efficacy of traditional preventive treatment. This test measures compliance to ASA therapy and helps determine whether current dosing is sufficient to effectively block the formation of harmful inflammatory agents. To learn more about this test, or to place an order, please visit the How to Order Tests page.
ARE YOU AT HIGH RISK FOR A NEAR-TERM CARDIOVASCULAR EVENT?
Assess from the bloodstream whether cardiovascular disease is actively progressing. High levels of myeloperoxidase may indicate that cardiac disease is actively progressing, and these levels are a significant predictor of higher likelihood of adverse event in the near future. To learn more about this test, or to place an order, please visit the How to Order Tests page.
DO YOU HAVE HIGH LEVELS OF RUPTURE-PRONE PLAQUE?
Assess the hidden presence of disease from inside the vessel wall with a focus on rupture-prone plaque. High levels of Lp-PLA2 demonstrate vascular specific inflammation and are significant predictors for the risk of heart attack and stroke. To learn more about this test, or to place an order, please visit the How to Order Tests page.